Quantitative analysis of associations between DNA hypermethylation, hypomethylation, and DNMT RNA levels in ovarian tumors

How hypermethylation and hypomethylation of different parts of the genome in cancer are related to each other and to DNA methyltransferase (DNMT) gene expression is ill defined. We used ovarian epithelial tumors of different malignant potential to look for associations between 5′-gene region or promoter hypermethylation, satellite, or global DNA hypomethylation, and RNA levels for ten DNMT isoforms. In the quantitative MethyLight assay, six of the 55 examined gene loci (LTB4R, MTHFR, CDH13, PGR, CDH1, and IGSF4) were significantly hypermethylated relative to the degree of malignancy (after adjustment for multiple comparisons; P<0.001). Importantly, hypermethylation of these genes was associated with degree of malignancy independently of the association of satellite or global DNA hypomethylation with degree of malignancy. Cancer-related increases in methylation of only two studied genes, LTB4R and MTHFR, which were appreciably methylated even in control tissues, were associated with DNMT1 RNA levels. Cancer-linked satellite DNA hypomethylation was independent of RNA levels for all DNMT3B isoforms, despite the ICF syndrome-linked DNMT3B deficiency causing juxtacentromeric satellite DNA hypomethylation. Our results suggest that there is not a simple association of gene hypermethylation in cancer with altered DNMT RNA levels, and that this hypermethylation is neither the result nor the cause of satellite and global DNA hypomethylation.

[1]  A. Feinberg,et al.  Limited up-regulation of DNA methyltransferase in human colon cancer reflecting increased cell proliferation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[2]  P. Laird,et al.  Hypomethylation and hypermethylation of DNA in Wilms tumors , 2002, Oncogene.

[3]  A. Kaneda,et al.  Frequent hypomethylation in multiple promoter CpG islands is associated with global hypomethylation, but not with frequent promoter hypermethylation , 2004, Cancer science.

[4]  M. Ehrlich,et al.  A DNA repeat, NBL2, is hypermethylated in some cancers but hypomethylated in others , 2005, Cancer biology & therapy.

[5]  S. Hirohashi,et al.  Overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, associated with DNA hypomethylation on pericentromeric satellite regions during human hepatocarcinogenesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[6]  P. Laird,et al.  MethyLight: a high-throughput assay to measure DNA methylation. , 2000, Nucleic acids research.

[7]  W. Schulz,et al.  Decrease of DNA methyltransferase 1 expression relative to cell proliferation in transitional cell carcinoma , 2003, International journal of cancer.

[8]  E. Viégas-Péquignot,et al.  Specific induction of uncoiling and recombination by azacytidine in classical satellite-containing constitutive heterochromatin. , 1993, Cytogenetics and cell genetics.

[9]  Christian B. Woods,et al.  Analysis of repetitive element DNA methylation by MethyLight , 2005, Nucleic acids research.

[10]  N. Draper,et al.  Applied Regression Analysis. , 1967 .

[11]  F. Ledeist,et al.  An embryonic-like methylation pattern of classical satellite DNA is observed in ICF syndrome. , 1993, Human molecular genetics.

[12]  R. Jaenisch,et al.  Chromosomal Instability and Tumors Promoted by DNA Hypomethylation , 2003, Science.

[13]  P. Argani,et al.  Increased Protein Stability Causes DNA Methyltransferase 1 Dysregulation in Breast Cancer* , 2005, Journal of Biological Chemistry.

[14]  L. Dubeau.  The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: does the emperor have no clothes? , 1999, Gynecologic oncology.

[15]  D. Wolfe,et al.  Nonparametric Statistical Methods. , 1974 .

[16]  K. Nephew,et al.  DNA methylation and ovarian cancer. I. Analysis of CpG island hypermethylation in human ovarian cancer using differential methylation hybridization. , 2001, Gynecologic oncology.

[17]  K. Robertson,et al.  The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. , 1999, Nucleic acids research.

[18]  W. Benedict,et al.  Genetic disparity between morphologically benign cysts contiguous to ovarian carcinomas and solitary cystadenomas. , 1995, Journal of the National Cancer Institute.

[19]  Max Costa,et al.  5-Azacytidine Induces Transgene Silencing by DNA Methylation in Chinese Hamster Cells , 1999, Molecular and Cellular Biology.

[20]  M. Ehrlich,et al.  DNA methylation in cancer: too much, but also too little , 2002, Oncogene.

[21]  Peter A. Jones,et al.  The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.

[22]  S. Baylin,et al.  High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[23]  D. Haber,et al.  DNA Methyltransferases Dnmt3a and Dnmt3b Are Essential for De Novo Methylation and Mammalian Development , 1999, Cell.

[24]  Christian B. Woods,et al.  Satellite DNA hypomethylation in karyotyped Wilms tumors. , 2003, Cancer genetics and cytogenetics.

[25]  Robert Brown,et al.  Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene. , 2003, Carcinogenesis.

[26]  A. Feinberg,et al.  Hypomethylation distinguishes genes of some human cancers from their normal counterparts , 1983, Nature.

[27]  R. Hruban,et al.  Aberrant Methylation of the 5' CpG Island of TSLC1 Is Common in Pancreatic Ductal Adenocarcinoma and Is First Manifest in High-Grade PanINs , 2002, Cancer biology & therapy.

[28]  R. Dahiya,et al.  Hypermethylation can selectively silence multiple promoters of steroid receptors in cancers , 2003, Molecular and Cellular Endocrinology.

[29]  P. Goodfellow,et al.  IGSF4 promoter methylation and expression silencing in human cervical cancer. , 2005, Gynecologic oncology.

[30]  I. Pogribny,et al.  Alterations in hepatic p53 gene methylation patterns during tumor progression with folate/methyl deficiency in the rat. , 1997, Cancer letters.

[31]  D. Ginty,et al.  Hypermethylated SUPERMAN Epigenetic Alleles in Arabidopsis , 1997 .

[32]  Y. Benjamini,et al.  Controlling the false discovery rate in behavior genetics research , 2001, Behavioural Brain Research.

[33]  C. Wijmenga,et al.  The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. Ehrlich,et al.  Preferential induction of chromosome 1 multibranched figures and whole-arm deletions in a human pro-B cell line treated with 5-azacytidine or 5-azadeoxycytidine. , 1997, Cytogenetics and cell genetics.

[35]  R. Ward,et al.  The relationship between hypomethylation and CpG island methylation in colorectal neoplasia. , 2003, The American journal of pathology.

[36]  M. Ehrlich,et al.  The 5-methylcytosine content of DNA from human tumors. , 1983, Nucleic acids research.

[37]  M. Lieber,et al.  The DNA methyltransferase-like protein DNMT3L stimulates de novo methylation by Dnmt3a , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[38]  M. Ehrlich,et al.  Satellite DNA hypomethylation vs. overall genomic hypomethylation in ovarian epithelial tumors of different malignant potential. , 1999, Mutation research.

[39]  A. Jeltsch,et al.  The Human Dnmt2 Has Residual DNA-(Cytosine-C5) Methyltransferase Activity* , 2003, Journal of Biological Chemistry.

[40]  A. Viel,et al.  Loss of heterozygosity at the 5,10-methylenetetrahydrofolate reductase locus in human ovarian carcinomas. , 1997, British Journal of Cancer.

[41]  A. Feinberg,et al.  DNA methylation and genomic imprinting: insights from cancer into epigenetic mechanisms. , 2002, Seminars in cancer biology.

[42]  C. Yue,et al.  Mechanisms of inactivation of E-cadherin in breast carcinoma: modification of the two-hit hypothesis of tumor suppressor gene , 2001, Oncogene.

[43]  M. Ehrlich,et al.  Demethylation and expression of methylated plasmid DNA stably transfected into HeLa cells. , 1999, Nucleic acids research.

[44]  L. Dubeau,et al.  Biology of ovarian cancer. , 1997, Current opinion in oncology.

[45]  S. Baylin,et al.  Hypomethylation of pericentromeric DNA in breast adenocarcinomas , 1998, International journal of cancer.

[46]  Y. Kodera,et al.  CDH13 promoter region is specifically methylated in poorly differentiated colorectal cancer , 2004, British Journal of Cancer.

[47]  En Li,et al.  A Novel Dnmt3a Isoform Produced from an Alternative Promoter Localizes to Euchromatin and Its Expression Correlates with Activede Novo Methylation* , 2002, The Journal of Biological Chemistry.

[48]  C. Mathew,et al.  Disruption of the Fanconi anemia–BRCA pathway in cisplatin-sensitive ovarian tumors , 2003, Nature Medicine.

[49]  Lixin Qi,et al.  Both Hypomethylation and Hypermethylation in a 0.2-kb Region of a DNA Repeat in Cancer , 2005, Molecular Cancer Research.

[50]  M. Ehrlich.  The ICF syndrome, a DNA methyltransferase 3B deficiency and immunodeficiency disease. , 2003, Clinical immunology.

[51]  Albert Jeltsch,et al.  Molecular Enzymology of the Catalytic Domains of the Dnmt3a and Dnmt3b DNA Methyltransferases* 210 , 2002, The Journal of Biological Chemistry.

[52]  W. Schulz,et al.  High frequency of alterations in DNA methylation in adenocarcinoma of the prostate , 1999, The Prostate.

[53]  Keith D Robertson,et al.  DNA methylation, methyltransferases, and cancer , 2001, Oncogene.

[54]  C. Borror.  Nonparametric Statistical Methods, 2nd, Ed. , 2001 .

[55]  M. Ehrlich,et al.  Frequent hypomethylation in Wilms tumors of pericentromeric DNA in chromosomes 1 and 16. , 1999, Cancer genetics and cytogenetics.

[56]  M. Ehrlich,et al.  Frequent DNA hypomethylation of human juxtacentromeric BAGE loci in cancer , 2005, Genes, chromosomes & cancer.

[57]  M. Widschwendter,et al.  DNA hypomethylation is prevalent even in low-grade breast cancers , 2004, Cancer biology & therapy.

[58]  M. Ehrlich,et al.  Amount and distribution of 5-methylcytosine in human DNA from different types of tissues of cells. , 1982, Nucleic acids research.

[59]  Tai-Lin Lee,et al.  The Eukaryotic DNMT2 Genes Encode a New Class of Cytosine-5 DNA Methyltransferases* , 2003, Journal of Biological Chemistry.

[60]  Peter W. Laird,et al.  DNA Hypomethylation and Ovarian Cancer Biology , 2004, Cancer Research.